Product Information

RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.6265 per EA under NDC 71921040506. Its NADAC has been published 60 times since Sep 24, 2025.

FDA first approved this application on Aug 11, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVAROXABAN 2.5 MG TABLET

rivaroxaban
$0.6265per EA

Strength

2.5 mg/1

NDC

71921040506

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIVAROXABAN

Approval Type

Generic (ANDA)

FDA Application

ANDA218445

FDA Approved

8/11/2025

TE Code

AB

On Market Since

8/20/2025

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 60 times since Sep 24, 2025, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6265 per EA
All-time high$3.3910 (Oct 15, 2025)
All-time low$0.6265 (Oct 21, 2026)
52-week high$1.6224
52-week low$0.6265
Median price$0.9675
Average price$1.2139
Largest weekly change-32.4% (Nov 19, 2025)
Weeks tracked60
Tracking sinceSep 24, 2025

Price History

1W

0.0%

1M

-3.6%

3M

-9.4%

6M

-34.5%

1Y

-73.9%

3Y

N/A

5Y

N/A

All

-81.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Florida Pharmaceutical Products, LLC, is $0.6265 per EA (NDC 71921040506), effective Nov 11, 2026.

How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 81.5%. It has been tracked across 60 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?

Since Sep 24, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.6265 (Oct 21, 2026) to a high of $3.3910 (Oct 15, 2025), with a median of $0.9675 per EA.

Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVAROXABAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVAROXABAN 2.5 MG TABLET?

RIVAROXABAN 2.5 MG TABLET (NDC 71921040506) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.